NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



Studies from Vanderbilt University, Medical Department yield new information about angiogenesis



April 8th, 2008

According to recent research published in the journal Blood, "To define the role of the alpha 2 beta 1 integrin in pathologic angiogenesis, we investigated tumor-associated growth and angiogenesis in wild-type and alpha 2-null mice. Our findings reveal that the alpha 2 beta 1 integrin plays an important role in angiogenesis via regulation of VEGFR1 expression."

"When challenged with B16F10 melanoma cells, mice lacking alpha 2 beta 1 integrin expression exhibit increased tumor angiogenesis associated with up-regulated VEGFR1 expression. In contrast, there was no alpha 2 beta 1 integrin-dependent difference in the angiogenic response to Lewis lung carcinoma (LLC)...


Source: Cancer Weekly (2008-04-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login